Takahisa Hirose

7PUBLICATIONS
13CO-AUTHORS
Epidemiological modellingPharmacogenomicsAboriginal and Torres Strait Islander medicine and treatmentsAboriginal and Torres Strait Islander and disabilityFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 08, 2026
Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes.

Genki Sato, Hiroshi Uchino, Kota Takuma

|Jun 25, 2025
Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY-CVR study.

Kohei Mochizuki, Ayako Fuchigami, Takahisa Hirose

|Aug 07, 2024
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study.

Genki Sato, Hiroshi Uchino, Takahisa Hirose

|Apr 12, 2023
Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub-analysis of the DIVERSITY-CVR study.

Kota Takuma, Ayako Fuchigami, Fumika Shigiyama

|Jan 21, 2022
Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background.

Fukumi Yoshikawa, Naoki Kumashiro, Fumika Shigiyama

|Feb 26, 2020
Effect of High β-glucan Barley on Postprandial Blood Glucose and Insulin Levels in Type 2 Diabetic Patients.

Yukie Fuse, Mariko Higa, Naoko Miyashita

Pageof 2

Frequent Collaborators

3 joint publications

Hiroshi Uchino

2 joint publications

Mariko Higa

2 joint publications

Yukie Fuse

2 joint publications

Naoko Miyashita